Fengbiao Mao

Dr. Fengbiao Mao


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 August 2024 in Signal Transduction and Targeted Therapy
Verified
Journal Article
Open access
PDF file
JSJimeng Su
Jimeng Su
YSYing Song
Ying Song
ZZZhipeng Zhu
Zhipeng Zhu
XHXinyue Huang
Xinyue Huang
JFJibiao Fan
Jibiao Fan
FMFengbiao Mao
Fengbiao Mao
Multicellular organisms are composed of diverse cell types that must coordinate their behaviors through communication. Cell–cell communication (CCC) is essential for growth, development, differentiation, tissue and organ formation, maintenance, and physiological regulation. Cells communicate through direct contact or at a distance using ligand–receptor interactions. So cellular communication encompasses two essential processes: cell signal conduction for generation and intercellular transmission of signals, and cell signal transduction for reception and procession of signals. Deciphering intercellular communication networks is critical for understanding cell differentiation, development, and metabolism. First, we comprehensively review the historical milestones in CCC studies, followed by a detailed description of the mechanisms of signal molecule transmission and the importance of the main signaling pathways they mediate in maintaining biological functions. Then we systematically introduce a series of human diseases caused by abnormalities in cell communication and their progress in clinical applications. Finally, we summarize various methods for monitoring cell interactions, including cell imaging, proximity-based chemical labeling, mechanical force analysis, downstream analysis strategies, and single-cell technologies. These methods aim to illustrate how biological functions depend on these interactions and the complexity of their regulatory signaling pathways to regulate crucial physiological processes, including tissue homeostasis, cell development, and immune responses in diseases. In addition, this review enhances our understanding of the biological processes that occur after cell–cell binding, highlighting its application in discovering new therapeutic targets and biomarkers related to precision medicine. This collective understanding provides a foundation for developing new targeted drugs and personalized treatments.

1 October 2018 in Cancer Cell
Verified
Journal Article
Closed access
YSYuqing Sun
Yuqing Sun
BZBo Zhou
Bo Zhou
FMFengbiao Mao
Fengbiao Mao
JXJing Xu
Jing Xu
HMHongzhi Miao
Hongzhi Miao
JHJay L. Hess
Jay L. Hess

28 December 2017 in The Journal of Pathology
Verified
Journal Article
Closed access
PDF file
JLJialong Liang
Jialong Liang
WCWanshi Cai
Wanshi Cai
DFDongdong Feng
Dongdong Feng
HTHuajing Teng
Huajing Teng
FMFengbiao Mao
Fengbiao Mao
ZSZhong Sun
Zhong Sun

12 November 2020 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
TWTao Wang
Tao Wang
SRShasha Ruan
Shasha Ruan
XZXiaolu Zhao
Xiaolu Zhao
XSXiaohui Shi
Xiaohui Shi
HTHuajing Teng
Huajing Teng
FMFengbiao Mao
Fengbiao Mao
The prevalence of neutral mutations in cancer cell population impedes the distinguishing of cancer-causing driver mutations from passenger mutations. To systematically prioritize the oncogenic ability of somatic mutations and cancer genes, we constructed a useful platform, OncoVar (https://oncovar.org/), which employed published bioinformatics algorithms and incorporated known driver events to identify driver mutations and driver genes. We identified 20 162 cancer driver mutations, 814 driver genes and 2360 pathogenic pathways with high-confidence by reanalyzing 10 769 exomes from 33 cancer types in The Cancer Genome Atlas (TCGA) and 1942 genomes from 18 cancer types in International Cancer Genome Consortium (ICGC). OncoVar provides four points of view, ‘Mutation’, ‘Gene’, ‘Pathway’ and ‘Cancer’, to help researchers to visualize the relationships between cancers and driver variants. Importantly, identification of actionable driver alterations provides promising druggable targets and repurposing opportunities of combinational therapies. OncoVar provides a user-friendly interface for browsing, searching and downloading somatic driver mutations, driver genes and pathogenic pathways in various cancer types. This platform will facilitate the identification of cancer drivers across individual cancer cohorts and helps to rank mutations or genes for better decision-making among clinical oncologists, cancer researchers and the broad scientific community interested in cancer precision medicine.

1 January 2018 in Theranostics
Verified
Journal Article
Open access
HTHuajing Teng
Huajing Teng
FMFengbiao Mao
Fengbiao Mao
JLJialong Liang
Jialong Liang
MXMeiying Xue
Meiying Xue
WWWenqing Wei
Wenqing Wei
ZSZhong Sun
Zhong Sun
Papillary thyroid carcinoma (PTC) is the fastest-growing disease caused by numerous molecular alterations in addition to previously reported DNA mutations. There is a compelling need to identify novel transcriptomic alterations that are associated with the pathogenesis of PTC with potential diagnostic and prognostic implications.

8 May 2017 in Molecular Biology and Evolution
Verified
Journal Article
Open access
PDF file
HTHuajing Teng
Huajing Teng
YZYaohua Zhang
Yaohua Zhang
CSCheng-Min Shi
Cheng-Min Shi
FMFengbiao Mao
Fengbiao Mao
WCWanshi Cai
Wanshi Cai
JZJianxu Zhang
Jianxu Zhang
Murine rodents are excellent models for study of adaptive radiations and speciation. Brown Norway rats (Rattus norvegicus) are successful global colonizers and the contributions of their domesticated laboratory strains to biomedical research are well established. To identify nucleotide-based speciation timing of the rat and genomic information contributing to its colonization capabilities, we analyzed 51 whole-genome sequences of wild-derived Brown Norway rats and their sibling species, R. nitidus, and identified over 20 million genetic variants in the wild Brown Norway rats that were absent in the laboratory strains, which substantially expand the reservoir of rat genetic diversity. We showed that divergence of the rat and its siblings coincided with drastic climatic changes that occurred during the Middle Pleistocene. Further, we revealed that there was a geographically widespread influx of genes between Brown Norway rats and the sibling species following the divergence, resulting in numerous introgressed regions in the genomes of admixed Brown Norway rats. Intriguing, genes related to chemical communications among these introgressed regions appeared to contribute to the population-specific adaptations of the admixed Brown Norway rats. Our data reveals evolutionary history of the Brown Norway rat, and offers new insights into the role of climatic changes in speciation of animals and the effect of interspecies introgression on animal adaptation.